Skip to content
Search
AI Powered
Latest Stories

Sensodyne maker planning widespread layoffs to cut cost

Sensodyne maker planning widespread layoffs to cut cost

Sensodyne maker is planning widespread layoffs in the UK and around the world as a part of cost-cutting plans a year after being spun off from Britain’s second-biggest drugmaker GSK.

Haleon, which has 24,000 staff across 170 countries, intends to cut hundreds of roles in the UK and potentially thousands worldwide, The Guardian reported on Thursday (13).


In the UK the firm employs 1,700 people, spread across its global headquarters and its research and development labs in Weybridge in Surrey, and a manufacturing site in Maidenhead. The company is one of the world’s biggest consumer healthcare groups and sells over-the-counter drugs, vitamins and oral care products.

According to the report, staff were briefed on the redundancies earlier this week in a series of meetings, and a consultation process. Some people will be offered other roles in the company and those who are laid off are expected to leave Haleon from September.

The job cuts are part of a broader cost-cutting programme aimed at saving £300 million in the next three years.

We’ve announced internally a number of changes across our global business this week, as we continue to evolve Haleon into a more agile organisation. As we shared in March, this is part of a broader three-year programme that will help drive increased productivity across the business, ensuring that Haleon continues to deliver for consumers over the long term," a spokesperson said.

“Any decisions that involve colleagues are not taken lightly, and as we enter a process of consultation in relevant markets, we are fully committed to supporting colleagues that may be impacted."

It was reported last week that Haleon is exploring a potential divestment of some smoking cessation products, including the Nicotinell brand of nicotine gum, patches and lozenges. Under Chief Executive Officer Brian McNamara, reports stated that Haleon has been looking to streamline its portfolio and focus on core products. The company was also exploring divesting of its ChapStick lip balm brand.

More for you

VApril 2025 UKVIA campaign poster promoting vaping as a quit-smoking tool
Photo: iStock

Vape awareness campaign to begin amid record-high misperceptions

VApril, the largest and most successful vape awareness campaign in the world, is returning for its eighth year amid record-high misperceptions around vaping and stop smoking tool.

Created by the UK Vaping Industry Association (UKVIA), the initiative comes at a critical time for the UK vaping sector, with half of smokers wrongly believing vaping is as harmful - or worse - than smoking.

Keep ReadingShow less
Tŷ Hywel launch of 2025 ACS Welsh Local Shop Report on March 26
iStock image

New report shows value of Wales' convenience stores

Almost all convenience stores in Wales engaged in some form of community activity last year, shows a latest report, shedding light on the value that Wales’ 3,000+ convenience stores provide as community hubs, local employers of over 26,000 people, and significant contributors to the Welsh economy.

Association of Convenience Stores (ACS) has officially launched its 2025 Welsh Local Shop Report, celebrating the key contributions that Welsh convenience stores make to their communities.

Keep ReadingShow less
UK inflation at 2.8% in Feb 2025 before Rachel Reeves’ budget speech
iStock image

Inflation dips as experts warn of  future spikes

British inflation slowed more than expected in February, bringing some relief to consumers ahead of a likely new pick-up in price growth and to finance minister Rachel Reeves before her budget update speech today (26). However, analysts have warned that it inflation will be pushed again soon due to costs arising from the Budget.

Consumer prices rose by 2.8 per cent in annual terms in February after a 3.0 per cent increase in January, the Office for National Statistics said, as clothing and footwear prices fell for the first time in more than three years.

Keep ReadingShow less
Fever-Tree premium mixers being served at an upscale London bar

Fever-Tree maintains market leadership despite shifting consumer trends

Fever-Tree range

Fever-Tree reports strong revenue growth

Premium mixer brand Fever-Tree saw its revenue growth accelerate to 7 per cent in the second half of its financial year to 31 December, helping it recover from a wet start to the summer season in 2024.

The firm’s total revenue was up 4 per cent to £364 million over the 12-month period, despite a 3 per cent drop to £111.1m in the UK, where low consumer sentiment and a declining gin category hit demand for its products.

Keep ReadingShow less